A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Cited by (692)

Items 101–200 of 692

1. Emerging concepts of epigenetic dysregulation in hematological malignancies
   Panagiotis Ntziachristos, Omar Ibrahim Abdel-Wahab, Iannis Aifantis · 2016 · Nature Immunology
2. 4C-ker: A Method to Reproducibly Identify Genome-Wide Interactions Captured by 4C-Seq Experiments
   Ramya Raviram, Pedro P. Rocha, Christian L. Müller, Emily R. Miraldi, Sana Badri, Yi Fu, Emily Swanzey, Charlotte Proudhon, Valentina Snetkova, Richard Bonneau et al. · 2016 · PLoS Computational Biology
3. INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma
   Bingying Zhou, Li Wang, Shu Zhang, Brian D. Bennett, Fan He, Yan Zhang, Chengliang Xiong, Leng Han, Lixia Diao, Pishun Li et al. · 2016 · Genes & Development
4. EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations
   Vincent‐Philippe Lavallée, Patrick Gendron, Sébastien Lemieux, Giovanni D’Angelo, Josée Hébert, Guy Sauvageau · 2014 · Blood
5. Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations
   Stanley Zhou, Aislinn E. Treloar, Mathieu Lupien · 2016 · Cancer Discovery
6. ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia
   Cécile Thirant, Cathy Ignacimouttou, Cécile K. Lopez, M'boyba Khadija Diop, Lou Le Mouël, Clarisse Thiollier, Aurélie Siret, Phillipe Dessen, Zakia Aid, Julie Rivière et al. · 2017 · Cancer Cell
7. Minor Loops in Major Folds: Enhancer–Promoter Looping, Chromatin Restructuring, and Their Association with Transcriptional Regulation and Disease
   Navneet Kaur Matharu, Nadav Ahituv · 2015 · PLoS Genetics
8. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms
   Qunying Jia, Shuhua Chen, Yuan Tan, Yuejin Li, Faqing Tang · 2020 · Experimental & Molecular Medicine
9. TADCompare: An R Package for Differential and Temporal Analysis of Topologically Associated Domains
   Kellen G. Cresswell, Mikhail G. Dozmorov · 2020 · Frontiers in Genetics
10. Illuminating the noncoding genome in cancer
    Xiaoyang Zhang, Matthew M. Meyerson · 2020 · Nature Cancer
11. Increased enhancer–promoter interactions during developmental enhancer activation in mammals
    Zhuoxin Chen, Valentina Snetkova, Grace Bower, Sandra H. Jacinto, Ben Clock, Atrin Dizehchi, Iros Barozzi, Brandon J. Mannion, Ana Alcaina‐Caro, Javier López-Rı́os et al. · 2024 · Nature Genetics
12. Chromatin architecture transitions from zebrafish sperm through early embryogenesis
    Candice L. Wike, Yixuan Guo, Mengyao Tan, Ryohei Nakamura, Dana Klatt Shaw, Noèlia Díaz, Aneasha F. Whittaker-Tademy, Neva C. Durand, Erez Lieberman Aiden, Juan M. Vaquerizas et al. · 2021 · Genome Research
13. Mutations in the noncoding genome
    Cheryl Scacheri, Peter C. Scacheri · 2015 · Current Opinion in Pediatrics
14. Super-lncRNAs: identification of lncRNAs that target super-enhancers via RNA:DNA:DNA triplex formation
    Benjamin Soibam · 2017 · RNA
15. Chromatin dependencies in cancer and inflammation
    Marazzi, Ivan, Greenbaum, Benjamin D., Low, Diana H. P., Guccione, Ernesto · 2018 · Nature Reviews Molecular Cell Biology
16. A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases
    Yiqun Zhang, Lixing Yang, Melanie H. Kucherlapati, Fengju Chen, Angela G. Hadjipanayis, Angeliki Pantazi, Christopher Aaron Bristow, Eunjung Alice Lee, Harshad S. Mahadeshwar, Jiabin Tang et al. · 2018 · Cell Reports
17. Current challenges in understanding the role of enhancers in disease
    Judith B. Zaugg, Pelin Sahlén, Robin Andersson, Meritxell Alberich-Jordà, Wouter L. de Laat, Bart Deplancke, Jorge P. Ferrer, Susanne Mandrup, Gioacchino Natoli, Dariusz Plewczyński et al. · 2022 · Nature Structural & Molecular Biology
18. GATA Transcription Factors: Basic Principles and Related Human Disorders
    Tohru Fujiwara · 2017 · The Tohoku Journal of Experimental Medicine
19. Super-enhancers and broad H3K4me3 domains form complex gene regulatory circuits involving chromatin interactions
    Cao, Fan, Fang, Yiwen, Tan, Hong Kee, Goh, Yufen, Choy, Jocelyn Yeen Hui, Koh, Bryan Thean Howe, Hao Tan, Jiong, Bertin, Nicolas, Ramadass, Aroul, Hunter, Ewan et al. · 2017 · Scientific Reports
20. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia
    Sophie Ottema, Roger Mulet‐Lazaro, H. Berna Beverloo, Claudia A. J. Erpelinck-Verschueren, Stanley van Herk, Robert M. van der Helm, Marije Havermans, Tim Grob, Peter J.M. Valk, Eric M. Bindels et al. · 2020 · Blood
21. Germline GATA2 Mutation and Bone Marrow Failure
    Lisa J. McReynolds, Katherine R. Calvo, Steven M. Holland · 2018 · Hematology/Oncology Clinics of North America
22. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
    Yiqun Zhang, Fengju Chen, Nuno A. Fonseca, Yao He, Masashi Fujita, Hidewaki Nakagawa, Zemin Zhang, Alvis Brāzma, PCAWG Transcriptome Working Group, Samirkumar B. Amin et al. · 2020 · Nature Communications
23. Understanding the 3D genome: Emerging impacts on human disease
    Anton Krumm, Zhijun Duan · 2018 · Seminars in Cell and Developmental Biology
24. Enhancers and chromatin structures: regulatory hubs in gene expression and diseases
    Zhenhua Hu, Wee‐Wei Tee · 2017 · Bioscience Reports
25. Mammalian Transcription Factor Networks: Recent Advances in Interrogating Biological Complexity
    Wilkinson, Adam C., Nakauchi, Hiromitsu, Göttgens, Berthold · 2017 · Cell Systems
26. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
    Emery H. Bresnick, Mabel Minji Jung, Koichi Ricardo Katsumura · 2020 · Blood Advances
27. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
    Jana Reimer, Sabine Knöß, Maurice Labuhn, Emmanuelle Charpentier, Gudrun Göhring, Brigitte Schlegelberger, Jan‐Henning Klusmann, Dirk Heckl · 2017 · Haematologica
28. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops
    Yu Guo, Andrew A. Perez, D. Hazelett, G. Coetzee, S. Rhie, P. Farnham · 2018 · Genome Biology
29. GATA2 deficiency syndrome: A decade of discovery
    Claire C. Homan, Parvathy Venugopal, Peer Arts, Nur Hezrin Shahrin, Simone K. Feurstein, Lesley H. Rawlings, David Lawrence, James Andrews, Sarah L. King‐Smith, Natasha L. Harvey et al. · 2021 · Human Mutation
30. A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers
    Noriko Sugino, Masahiro Kawahara, Goichi Tatsumi, Akinori Kanai, Hirotaka Matsui, Ryō Yamamoto, Yuya Nagai, S Fujii, Yayoi Shimazu, Masakatsu Hishizawa et al. · 2017 · Leukemia
31. Super Enhancers in Cancers, Complex Disease, and Developmental Disorders
    Adrienne R. Niederriter, Arushi Varshney, Stephen C.J. Parker, Donna M. Martin · 2015 · Genes
32. Review: Aberrant EVI 1 expression in acute myeloid leukaemia
    Adil S. A. Al Hinai, Peter J.M. Valk · 2016 · British Journal of Haematology
33. Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation
    Tushar Damodar Bhagat, Si Chen, Matthias Bartenstein, A. Trevor Barlowe, Dagny Von Ahrens, Gaurav S. Choudhary, Patrick Tivnan, Elianna Mohamed Amin, A. Mario Marcondes, Mathijs Arnoud Sanders et al. · 2017 · Cancer Research
34. Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms
    Anouk Emadali, Neda Hoghoughi, Samuel Duley, Azadeh Hajmirza, Els Verhoeyen, François‐Loïc Cosset, Philìppe Bertrand, Christophe Roumier, Anne Roggy, Céline Suchaud-Martin et al. · 2016 · Blood
35. Cancer stem cells: a potential target for cancer therapy
    Hong Ying Qiu, Xiaoguang Fang, Qi Luo, Gaoliang Ouyang · 2015 · Cellular and Molecular Life Sciences
36. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1
    Ying Ying, Yejun Wang, Xiaoyan Huang, Yanmei Sun, Junbao Zhang, Meiqi Li, Junhui Zeng, Maolin Wang, Wenjun Xiao, Lan Zhong et al. · 2019 · Oncogene
37. Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation
    Hongbo Yang, Hui Zhang, Yu Luan, Tingting Liu, Wentao Yang, Kathryn G. Roberts, Maoxiang Qian, Bo Zhang, Wenjian Yang, Virginia Pérez-Andreu et al. · 2022 · Nature Genetics
38. PAX8 and MECOM are interaction partners driving ovarian cancer
    Melusine Bleu, Fanny Mermet‐Meillon, Verena Apfel, Louise Barys, Laura Holzer, Marianne Bachmann Salvy, Rui Lopes, Inês Amorim Monteiro Barbosa, Cecile Delmas, Alexandra Hinniger et al. · 2021 · Nature Communications
39. GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells
    Koichi Ricardo Katsumura, Irene M. Ong, Andrew DeVilbiss, Rajendran Sanalkumar, Emery H. Bresnick · 2016 · Cell Reports
40. Murine Models of Acute Myeloid Leukaemia
    Marwa Almosailleakh, Juerg Schwaller · 2019 · International Journal of Molecular Sciences
41. High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML
    Yue Zhao, Qi Liu, Pankaj Acharya, Kristy R. Stengel, Quanhu Sheng, Xiaofan Zhou, Hojoong Kwak, Melissa Ann Fischer, James E. Bradner, Stephen Anthony Strickland et al. · 2016 · Cell Reports
42. Reprogramming: identifying the mechanisms that safeguard cell identity
    Justin Brumbaugh, Bruno Di Stefano, Konrad Hochedlinger · 2019 · Development
43. Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor
    Jiajun Zhang, Weihai Liu, Changye Zou, Zhiqiang Zhao, Yuanying Lai, Zhi Shi, Xianbiao Xie, Gang Huang, Yongqian Wang, Xuelin Zhang et al. · 2020 · Clinical Cancer Research
44. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
    Wei Wang, Jörge E. Cortes, Pei Lin, Michael W. Beaty, Di Ai, Hesham M. Amin, Timothy J. McDonnell, Chi Young Ok, Hagop M. Kantarjian, Leonard Jeffrey Medeiros et al. · 2015 · Blood
45. Cis-regulatory mechanisms governing stem and progenitor cell transitions
    Kirby D. Johnson, Guangyao Kong, Xin Gao, Yuan‐I Chang, Kyle J. Hewitt, Rajendran Sanalkumar, Rajalekshmi Prathibha, Erik A. Ranheim, Colin N. Dewey, Jing Zhang et al. · 2015 · Science Advances
46. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops
    Sophie Ottema, Roger Mulet‐Lazaro, Claudia A. J. Erpelinck-Verschueren, Stanley van Herk, Marije Havermans, Andrea Arricibita Varea, Michael Vermeulen, H. Berna Beverloo, Stefan Gröschel, Torsten Haferlach et al. · 2021 · Nature Communications
47. Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
    Peter J. Cook, Rozario Thomas, Ram Kannan, Esther León, Alexander Edward Dela Cruz Drilon, Marc K. Rosenblum, Maurizio Scaltriti, Robert Benezra, Andrea Ventura · 2017 · Nature Communications
48. Structure, function and evolution of topologically associating domains (TADs) atHOX loci
    Nicolas Lonfat, Denis Duboule · 2015 · FEBS Letters
49. A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia
    Richard A. Voit, Liming Tao, Fulong Yu, Liam D. Cato, Blake Cohen, Travis J. Fleming, Mateusz Antoszewski, Xiaotian Liao, Claudia Fiorini, Satish Kumar Nandakumar et al. · 2022 · Nature Immunology
50. A Conserved Noncoding Locus Regulates Random Monoallelic Xist Expression across a Topological Boundary
    Rafael Galupa, Elphège Pierre Nora, Rebecca Worsley-Hunt, Christel Picard, Chris Gard, Joke Gerarda van Bemmel, Nicolas Servant, Yinxiu Zhan, Fatima El Marjou, Colin Johanneau et al. · 2019 · Molecular Cell
51. The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics
    Hong‐Yi Lin, Ah‐Jung Jeon, Kaina Chen, Chang Jie Mick Lee, Lingyan Wu, Shay-Lee Chong, Chukwuemeka George Anene-Nzelu, Roger Foo, Pierce K. H. Chow · 2025 · British Journal of Cancer
52. Clinical implications of molecular markers in acute myeloid leukemia
    Sabine Käyser, Mark J. Levis · 2018 · European Journal Of Haematology
53. Applying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers
    Rui Lopes, Gözde Korkmaz, Reuven Agami · 2016 · Nature Reviews Molecular Cell Biology
54. Interplay between CTCF boundaries and a super enhancer controls cohesin extrusion trajectories and gene expression
    Erica S.M. Vos, Christian Valdes‐Quezada, Yike Huang, Amin Allahyar, Marjon J.A.M. Verstegen, Anna-Karina Felder, Floor van der Vegt, Esther C. H. Uijttewaal, Peter H.L. Krijger, Wouter L. de Laat · 2021 · Molecular Cell
55. When TADs go bad: Chromatin structure and nuclear organisation in human disease
    Kaiser, Vera B, Semple, Colin A · 2017 · F1000Research
56. Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia
    Raman B. Sood, Nancy Fisher Hansen, Frank X. Donovan, Blake Carrington, Donna M. Bucci, Baishali Maskeri, Alice Young, Niraj S Trivedi, Jessica Kohlschmidt, Richard Maury Stone et al. · 2015 · Leukemia
57. MyoD- and FoxO3-mediated hotspot interaction orchestrates super-enhancer activity during myogenic differentiation
    Xianlu L. Peng, Karl Kam Hei So, Liangqiang He, Yu Fen Zhao, Jiajian Zhou, Yuying Li, Mingze Yao, Bo Xu, Suyang Zhang, Hongjie Yao et al. · 2017 · Nucleic Acids Research
58. CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
    Musaddeque Ahmed, Fraser Soares, Ji-Han Xia, Yue Yang, Jing Li, Hai-Yang Guo, Pei-Ran Su, Yi-Jun Tian, H. Lee, Miranda Wang et al. · 2021 · Nature Communications
59. A Practical Guide for Structural Variation Detection in the Human Genome
    Lixing Yang · 2020 · Current Protocols in Human Genetics
60. 3D genome organization in health and disease: emerging opportunities in cancer translational medicine
    Deepak Babu, Melissa J. Fullwood · 2015 · Nucleus
61. Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes
    Noemi A. Zambetti, Eric M. Bindels, Paulina M. H. van Strien, Marijke G. Valkhof, Maria Niken Adisty, Remco Michiel Hoogenboezem, M. A. Sanders, Johanna M. Rommens, Ivo P. Touw, Marc H.G.P. Raaijmakers · 2015 · Haematologica
62. Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies
    Kailong Li, Yuannyu Zhang, Xin Liu, Yuxuan Liu, Zhimin Gu, Hui Cao, Kathryn E. Dickerson, Mingyi Chen, Weina Chen, Zhen Shao et al. · 2020 · Cancer Discovery
63. EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
    Christine E. Birdwell, Warren C. Fiskus, Tapan Mahendra Kadia, Courtney Denton Dinardo, Christopher Peter Mill, Kapil N. Bhalla · 2021 · Blood Cancer Journal
64. Enhancer-gene specificity in development and disease
    Tomás Pachano, Endika Haro, Álvaro Rada-Iglesias · 2022 · Development
65. MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies
    Tim Ripperger, Winfried A. Hofmann, Jan Christoph Koch, Katayoon Shirneshan, Detlef Thomas Haase, Gerald Georg Wulf, Peter Rolf Issing, M. Karnebogen, Gunnar Schmidt, Bernd Auber et al. · 2017 · Haematologica
66. Chromatin loop anchors are associated with genome instability in cancer and recombination hotspots in the germline
    V. Kaiser, C. Semple · 2017 · Genome Biology
67. Chromatin Conformation in Development and Disease
    Ilias Boltsis, Frank G. Grosveld, Guillaume Giraud, Petros Kolovos · 2021 · Frontiers in Cell and Developmental Biology
68. Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs
    Subramanian, Shruthi, Thoms, Julie A. I., Huang, Yizhou, Cornejo-Páramo, Paola, Koch, Forrest C., Jacquelin, Sebastien, Shen, Sylvie, Song, Emma, Joshi, Swapna, Brownlee, Chris et al. · 2023 · Blood
69. RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
    Justin Ching Ting Loke, Salam Adli Assi, Maria Rosaria Imperato, Anetta Ptasinska, Pierre Cauchy, Yura Grabovska, Natalia Martinez-Soria, Manoj Raghavan, Ruud Delwel, Peter N. Cockerill et al. · 2017 · Cell Reports
70. Yap1-Driven Intestinal Repair Is Controlled by Group 3 Innate Lymphoid Cells
    Mónica Romera‐Hernández, Patricia Aparicio‐Domingo, Natalie Papazian, Julien J. Karrich, Ferry Cornelissen, Remco Michiel Hoogenboezem, Janneke N. Samsom, Tom Cupedo · 2020 · Cell Reports
71. CTCF chromatin residence time controls three-dimensional genome organization, gene expression and DNA methylation in pluripotent cells
    Widia Soochit, Frank Sleutels, Grégoire Stik, Marek Bartkuhn, Sreya Basu, Silvia C. Hernández, Sarra Merzouk, Enrique Vidal, Ruben Boers, Joachim Boers et al. · 2021 · Nature Cell Biology
72. Three-dimensional genome organization in immune cell fate and function
    Sergi Cuartero, Grégoire Stik, Ralph Stadhouders · 2022 · Nature reviews. Immunology
73. Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
    Paresh Vyas, Frederick R. Appelbaum, Charles Craddock · 2014 · Transplantation and Cellular Therapy
74. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia
    Lu Yang, Fengling Chen, Hai-Chuan Zhu, Yang Chen, B. Dong, Ming-Lei Shi, Weitao Wang, Q. Jiang, Le-Ping Zhang, X. Huang et al. · 2021 · Nature Communications
75. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
    Álex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Díaz‐Beyá, Montserrat Arnán, Mar Tormo, Susana Vives, Maria Paz Queipo De Llano, Rosa Coll et al. · 2021 · Blood Advances
76. Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias
    Brittany Knick Ragon, Hagop M. Kantarjian, Elias Joseph Jabbour, Farhad Ravandi, Jörge E. Cortes, Gautam M. Borthakur, LaKiesha Debose, Zhihong Zeng, Heather Schneider, Naveen Pemmaraju et al. · 2016 · American Journal of Hematology
77. Enhancer–promoter specificity in gene transcription: molecular mechanisms and disease associations
    Meyer J. Friedman, Tobias Wagner, Haram Lee, Michael G. Rosenfeld, Soohwan Oh · 2024 · Experimental & Molecular Medicine
78. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
    Edward Ayoub, Michael P. Wilson, Kathleen E. McGrath, Allison J. Li, Benjamin J. Frisch, James Palis, Laura Maria Calvi, Yi Zhang, Archibald S. Perkins · 2018 · Nature Communications
79. Nanopore sequencing of DNA concatemers reveals higher-order features of chromatin structure
    Netha Ulahannan, Matthew Pendleton, Aditya S. Deshpande, Stefan Schwenk, Julie M. Behr, Xiaoguang Dai, Carly Tyer, Priyesh Rughani, Sarah Kudman, Emily M. Adney et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
80. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program
    Charu Mehta, Kirby D. Johnson, Xin Gao, Irene M. Ong, Koichi Ricardo Katsumura, Skye C McIver, Erik A. Ranheim, Emery H. Bresnick · 2017 · Cell Reports
81. Epigenetics in normal and malignant hematopoiesis: An overview and update 2017
    Susumu Goyama, Toshio Kitamura · 2017 · Cancer Science
82. Super-enhancers complexes zoom in transcription in cancer
    MengTing Wang, Qingyang Chen, ShuJie Wang, Han Xie, Jun Liu, Ruixiang Huang, Yufei Xiang, Yan‐Yi Jiang, Dasheng Tian, Erbao Bian · 2023 · Journal of Experimental & Clinical Cancer Research
83. Computational Prediction of Position Effects of Apparently Balanced Human Chromosomal Rearrangements
    Cinthya J. Zepeda‐Mendoza, Jonas Ibn-Salem, Tammy Kammin, David J. Harris, Debra Rita, Karen Webster Gripp, Jennifer J. MacKenzie, Andrea Lynne Gropman, Brett H. Graham, Ranad Shaheen et al. · 2017 · The American Journal of Human Genetics
84. Human leukemia mutations corrupt but do not abrogate GATA-2 function
    Koichi Ricardo Katsumura, Charu Mehta, Kyle J. Hewitt, Alexandra A. Soukup, Isabela Fraga de Andrade, Erik A. Ranheim, Kirby D. Johnson, Emery H. Bresnick · 2018 · Proceedings of the National Academy of Sciences
85. Copy number alterations unmasked as enhancer hijackers
    Beroukhim, Rameen, Zhang, Xiaoyang, Meyerson, Matthew · 2017 · Nature Genetics
86. Dysregulation of cancer genes by recurrent intergenic fusions
    Jae Won Yun, Lixing Yang, Hye-Young Park, Chang‐Woo Lee, Hongui Cha, Hyun‐Tae Shin, Ka‐Won Noh, Yoon‐La Choi, Woong‐Yang Park, Peter J. Park · 2020 · Genome biology
87. GATA-related hematologic disorders
    Ritsuko Shimizu, Masayuki P. Yamamoto · 2016 · Experimental Hematology
88. Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
    Jinshou Yang, Feihan Zhou, Xiyuan Luo, Yuan Fang, Xing Wang, Xiaohong Liu, Ruiling Xiao, Decheng Jiang, Yuemeng Tang, Gang Yang et al. · 2025 · Cell Death Discovery
89. Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
    Cihangir Duy, Matt R. Teater, Francine E. Garrett-Bakelman, Tak C. Lee, Cem Meydan, Jacob Lowell Glass, Meng Li, Johannes C. Hellmuth, Helai P. Mohammad, Kimberly N. Smitheman et al. · 2019 · Cancer Discovery
90. Disruption of the 3D Cancer Genome Blueprint
    Joanna Achinger-Kawecka, Susan J. Clark · 2016 · Epigenomics
91. Enhancer dysfunction in leukemia
    Anand S. Bhagwat, Bin Lu, Christopher R. Vakoc · 2018 · Blood
92. The genomics of acute myeloid leukemia in children
    Shannon E. Conneely, Rachel E. Rau · 2020 · Cancer and Metastasis Reviews
93. Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis
    Wenjun Wang, Lingyu Li, Jiuwei Cui · 2020 · Epigenetics & Chromatin
94. Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells
    Julie A.I. Thoms, Peter Truong, Shruthi Subramanian, Kathy Knezevic, Gregory Harvey, Yizhou Huang, Janith A. Seneviratne, Daniel R. Carter, Swapna Mahurkar Joshi, Joanna N. Skhinas et al. · 2021 · Blood
95. Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML)
    Thorsten Braun, Claude Gardin · 2017 · Expert Opinion on Investigational Drugs
96. GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis
    Saori Katayama, Mikiko Suzuki, Ayaka Yamaoka, Nadine Keleku-Lukwete, Fumiki Katsuoka, Akihito Otsuki, Shigeo Kure, James Douglas Engel, Masayuki P. Yamamoto · 2017 · Blood
97. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation
    Martín A. Rivas, Cem Meydan, Christopher R. Chin, Matt F. Challman, Daleum Kim, Bhavneet Bhinder, Andreas Kloetgen, Aaron D. Viny, Matt R. Teater, Dylan R. McNally et al. · 2021 · Nature Immunology
98. EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
    Shuang Cui, Qiong Wu, Ming Liu, Mu Su, ShiYou Liu, Lan Shao, Xiao Han, Hongjuan He · 2021 · Cell Death and Disease
99. Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia
    Leonie Smeenk, Sophie Ottema, Roger Mulet‐Lazaro, Anja Ebert, Marije Havermans, Andrea Arricibita Varea, Michaela Fellner, Dorien Pastoors, Stanley van Herk, Claudia A. J. Erpelinck-Verschueren et al. · 2021 · Cancer Discovery
100. Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements
     Paul Kerbs, Sebastian Vosberg, Stefan Krebs, Alexander Graf, Helmut Blum, Anja Swoboda, Aarif M.N. Batcha, Ulrich Mansmann, Dirk Metzler, Caroline Akemi Heckman et al. · 2021 · Haematologica